Vertaling van "which is used " (Nederlands → Frans) :

1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines
1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines

From this starting point it proposes several areas on which to focus first and in which it would be useful to develop new models or at the very least, to optimise the facilities currently being used.
Partant de là, il propose différents champs d’action prioritaires dans lesquels il serait utile de développer de nouveaux modèles ou au minimum d’optimaliser les dispositifs existants.

Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission
Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission

It is crucial to take advantage of the moment of crisis and the moment at which the suicidal act is being carried out to make extensive use of the issues of the patient as well as those of the whole system of which he/she forms a part.
Il est capital de profiter du moment de crise et de passage à l’acte suicidaire pour mobiliser de manière intensive la problématique du patient mais aussi de tout le système dans lequel il s’intègre.

The term “minor depressive disorder”, which is often diagnosed in studies on depression, is used for describing the syndromes that are situated below the cut-off score that is used for a major depression.
Le terme de « trouble dépressif mineur » qui est souvent diagnostiqué dans les études portant sur la dépression est utilisé pour décrire les syndromes qui se situent au-dessous du seuil de sévérité retenu pour la dépression majeure.

In fact, the website (www.werkgroepverder.be) is an essential instrument of the working group Verder, not only because it is used to announce future actions and spread information, but also because it allows the bereaved to contact each other (“leg contacten” – “Forum”) anonymously and by e-mail, which for many people lowers the threshold for actually making use of it.
Le site Internet (www.werkgroepverder.be) est d’ailleurs un instrument essentiel pour le groupe de travail Verder. Non seulement pour annoncer des actions et pour diffuser de l’information, mais également parce qu’il permet aux proches d’entrer en contact (« leg contacten » – « Forum ») de façon anonyme et par e-mail, ce qui, pour beaucoup de gens, diminue le seuil pour réellement s’en servir.

Another aspect of this finding which has to do with the relation between depression and suicide concerns the means used to carry out the act: sometimes antidepressants prescribed for treating depression are used to commit suicide.
Un autre aspect de ce constat qui relève de la relation entre dépression et suicide concerne le moyen utilisé pour commettre l’acte: les antidépresseurs prescrits pour le traitement de la dépression sont parfois utilisés à des fins suicidaires.

In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.
In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.

The primary objectives of the SOE-USE in the initial phase are to train these employees and to develop an infrastructure which will enable collaboration and data exchange between members.
The primary objectives of the SOE-USE in the initial phase are to train these employees and to develop an infrastructure which will enable collaboration and data exchange between members.

Currently priority is focused on the awareness campaigns for healthcare professionals which are intended to promote the utility and importance of reporting pharmacovigilance of medicines for human and veterinary use.
Currently priority is focused on the awareness campaigns for healthcare professionals which are intended to promote the utility and importance of reporting pharmacovigilance of medicines for human and veterinary use.